Skip to main content
Erschienen in: European Journal of Nutrition 2/2017

21.12.2015 | Original Contribution

A possible role for ghrelin, leptin, brain-derived neurotrophic factor and docosahexaenoic acid in reducing the quality of life of coeliac disease patients following a gluten-free diet

verfasst von: Francesco Russo, Guglielmina Chimienti, Caterina Clemente, Carla Ferreri, Antonella Orlando, Giuseppe Riezzo

Erschienen in: European Journal of Nutrition | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

A gluten-free diet (GFD) has been reported to negatively impact the quality of life (QoL) of coeliac disease (CD) patients. The gut–brain axis hormones ghrelin and leptin, with the brain-derived neurotrophic factor (BDNF), may affect QoL of CD patients undergoing GFD. Our aims were to evaluate whether: (a) the circulating concentrations of leptin, ghrelin and BDNF in CD patients were different from those in healthy subjects; (b) GFD might induce changes in their levels; (c) BDNF Val66Met polymorphism variability might affect BDNF levels; and (d) serum BDNF levels were related to dietary docosahexaenoic acid (DHA) as a neurotrophin modulator.

Methods

Nineteen adult coeliac patients and 21 healthy controls were included. A QoL questionnaire was administered, and serum concentrations of ghrelin, leptin, BDNF and red blood cell membrane DHA levels were determined at the enrolment and after 1 year of GFD. BDNF Val66Met polymorphism was analysed.

Results

Results from the questionnaire indicated a decline in QoL after GFD. Ghrelin and leptin levels were not significantly different between groups. BDNF levels were significantly (p = 0.0213) lower in patients after GFD (22.0 ± 2.4 ng/ml) compared to controls (31.2 ± 2.2 ng/ml) and patients at diagnosis (25.0 ± 2.5 ng/ml). BDNF levels correlated with DHA levels (p = 0.008, r = 0.341) and the questionnaire total score (p = 0.041, r = 0.334).

Conclusions

Ghrelin and leptin seem to not be associated with changes in QoL of patients undergoing dietetic treatment. In contrast, a link between BDNF reduction and the vulnerability of CD patients to psychological distress could be proposed, with DHA representing a possible intermediate.
Literatur
2.
Zurück zum Zitat Pascual V, Dieli-Crimi R, Lopez-Palacios N, Bodas A, Medrano LM, Nunez C (2014) Inflammatory bowel disease and celiac disease: overlaps and differences. World J Gastroenterol (WJG) 20:4846–4856. doi:10.3748/wjg.v20.i17.4846 CrossRef Pascual V, Dieli-Crimi R, Lopez-Palacios N, Bodas A, Medrano LM, Nunez C (2014) Inflammatory bowel disease and celiac disease: overlaps and differences. World J Gastroenterol (WJG) 20:4846–4856. doi:10.​3748/​wjg.​v20.​i17.​4846 CrossRef
4.
Zurück zum Zitat Sainsbury K, Mullan B, Sharpe L (2013) Reduced quality of life in coeliac disease is more strongly associated with depression than gastrointestinal symptoms. J Psychosom Res 75:135–141CrossRef Sainsbury K, Mullan B, Sharpe L (2013) Reduced quality of life in coeliac disease is more strongly associated with depression than gastrointestinal symptoms. J Psychosom Res 75:135–141CrossRef
5.
Zurück zum Zitat Karwautz A, Wagner G, Berger G, Sinnreich U, Grylli V, Huber W-D (2008) Eating pathology in adolescents with celiac disease. Psychosomatics 49:399–406CrossRef Karwautz A, Wagner G, Berger G, Sinnreich U, Grylli V, Huber W-D (2008) Eating pathology in adolescents with celiac disease. Psychosomatics 49:399–406CrossRef
6.
Zurück zum Zitat Barratt SM, Leeds JS, Sanders DS (2011) Quality of life in Coeliac disease is determined by perceived degree of difficulty adhering to a gluten-free diet, not the level of dietary adherence ultimately achieved. J Gastrointestin Liver Dis 20:241–245 Barratt SM, Leeds JS, Sanders DS (2011) Quality of life in Coeliac disease is determined by perceived degree of difficulty adhering to a gluten-free diet, not the level of dietary adherence ultimately achieved. J Gastrointestin Liver Dis 20:241–245
7.
Zurück zum Zitat Samasca G, Sur G, Lupan I, Deleanu D (2014) Gluten-free diet and quality of life in celiac disease. Gastroenterol Hepatol Bed Bench 7:139–143 Samasca G, Sur G, Lupan I, Deleanu D (2014) Gluten-free diet and quality of life in celiac disease. Gastroenterol Hepatol Bed Bench 7:139–143
8.
Zurück zum Zitat Casellas F, Rodrigo L, Lucendo AJ, Fernandez-Banares F, Molina-Infante J, Vivas S, Rosinach M, Duenas C, Lopez-Vivancos J (2015) Benefit on health-related quality of life of adherence to gluten-free diet in adult patients with celiac disease. Rev Esp Enferm Dig 107:196–201 Casellas F, Rodrigo L, Lucendo AJ, Fernandez-Banares F, Molina-Infante J, Vivas S, Rosinach M, Duenas C, Lopez-Vivancos J (2015) Benefit on health-related quality of life of adherence to gluten-free diet in adult patients with celiac disease. Rev Esp Enferm Dig 107:196–201
9.
Zurück zum Zitat Nachman F, del Campo MP, Gonzalez A, Corzo L, Vazquez H, Sfoggia C, Smecuol E, Sanchez MIP, Niveloni S, Sugai E, Maurino E, Bai JC (2010) Long-term deterioration of quality of life in adult patients with celiac disease is associated with treatment noncompliance. Dig Liver Dis 42:685–691CrossRef Nachman F, del Campo MP, Gonzalez A, Corzo L, Vazquez H, Sfoggia C, Smecuol E, Sanchez MIP, Niveloni S, Sugai E, Maurino E, Bai JC (2010) Long-term deterioration of quality of life in adult patients with celiac disease is associated with treatment noncompliance. Dig Liver Dis 42:685–691CrossRef
10.
Zurück zum Zitat Hallert C, Granno C, Hulten S, Midhagen G, Strom M, Svensson H, Valdimarsson T (2002) Living with coeliac disease: controlled study of the burden of illness. Scand J Gastroenterol 37:39–42CrossRef Hallert C, Granno C, Hulten S, Midhagen G, Strom M, Svensson H, Valdimarsson T (2002) Living with coeliac disease: controlled study of the burden of illness. Scand J Gastroenterol 37:39–42CrossRef
11.
Zurück zum Zitat Usai P, Manca R, Cuomo R, Lai MA, Boi MF (2007) Effect of gluten-free diet and co-morbidity of irritable bowel syndrome-type symptoms on health-related quality of life in adult coeliac patients. Dig Liver Dis 39:824–828. doi:10.1016/j.dld.2007.05.017 CrossRef Usai P, Manca R, Cuomo R, Lai MA, Boi MF (2007) Effect of gluten-free diet and co-morbidity of irritable bowel syndrome-type symptoms on health-related quality of life in adult coeliac patients. Dig Liver Dis 39:824–828. doi:10.​1016/​j.​dld.​2007.​05.​017 CrossRef
12.
Zurück zum Zitat Papastamataki M, Papassotiriou I, Bartzeliotou A, Vazeou A, Roma E, Chrousos GP, Kanaka-Gantenbein C (2014) Incretins, amylin and other gut-brain axis hormones in children with coeliac disease. Eur J Clin Invest 44:74–82. doi:10.1111/eci.12193 CrossRef Papastamataki M, Papassotiriou I, Bartzeliotou A, Vazeou A, Roma E, Chrousos GP, Kanaka-Gantenbein C (2014) Incretins, amylin and other gut-brain axis hormones in children with coeliac disease. Eur J Clin Invest 44:74–82. doi:10.​1111/​eci.​12193 CrossRef
13.
Zurück zum Zitat Riezzo G, Ferreri C, Orlando A, Martulli M, D’Attoma B, Russo F (2014) Lipidomic analysis of fatty acids in erythrocytes of coeliac patients before and after a gluten-free diet intervention: a comparison with healthy subjects. Br J Nutr 112:1787–1796. doi:10.1017/S0007114514002815 CrossRef Riezzo G, Ferreri C, Orlando A, Martulli M, D’Attoma B, Russo F (2014) Lipidomic analysis of fatty acids in erythrocytes of coeliac patients before and after a gluten-free diet intervention: a comparison with healthy subjects. Br J Nutr 112:1787–1796. doi:10.​1017/​S000711451400281​5 CrossRef
14.
Zurück zum Zitat Miyazawa D, Yasui Y, Yamada K, Ohara N, Okuyama H (2010) Regional differences of the mouse brain in response to an alpha-linolenic acid-restricted diet: neurotrophin content and protein kinase activity. Life Sci 87:490–494CrossRef Miyazawa D, Yasui Y, Yamada K, Ohara N, Okuyama H (2010) Regional differences of the mouse brain in response to an alpha-linolenic acid-restricted diet: neurotrophin content and protein kinase activity. Life Sci 87:490–494CrossRef
15.
Zurück zum Zitat Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML (2001) Circulating ghrelin levels are decreased in human obesity. Diabetes 50:707–709CrossRef Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML (2001) Circulating ghrelin levels are decreased in human obesity. Diabetes 50:707–709CrossRef
16.
Zurück zum Zitat Spencer SJ, Xu L, Clarke MA, Lemus M, Reichenbach A, Geenen B, Kozicz T, Andrews ZB (2012) Ghrelin regulates the hypothalamic-pituitary-adrenal axis and restricts anxiety after acute stress. Biol Psychiatry 72:457–465. doi:10.1016/j.biopsych.2012.03.010 CrossRef Spencer SJ, Xu L, Clarke MA, Lemus M, Reichenbach A, Geenen B, Kozicz T, Andrews ZB (2012) Ghrelin regulates the hypothalamic-pituitary-adrenal axis and restricts anxiety after acute stress. Biol Psychiatry 72:457–465. doi:10.​1016/​j.​biopsych.​2012.​03.​010 CrossRef
19.
Zurück zum Zitat Friedman JM (2002) The function of leptin in nutrition, weight, and physiology. Nutr Rev 60:S1–S14 (discussion S68–S84, 85-17) CrossRef Friedman JM (2002) The function of leptin in nutrition, weight, and physiology. Nutr Rev 60:S1–S14 (discussion S68–S84, 85-17) CrossRef
20.
Zurück zum Zitat Linkov F, Burke LE, Komaroff M, Edwards RP, Lokshin A, Styn MA, Tseytlin E, Freese KE, Bovbjerg DH (2014) An exploratory investigation of links between changes in adipokines and quality of life in individuals undergoing weight loss interventions: possible implications for cancer research. Gynecol Oncol 133:67–72CrossRef Linkov F, Burke LE, Komaroff M, Edwards RP, Lokshin A, Styn MA, Tseytlin E, Freese KE, Bovbjerg DH (2014) An exploratory investigation of links between changes in adipokines and quality of life in individuals undergoing weight loss interventions: possible implications for cancer research. Gynecol Oncol 133:67–72CrossRef
21.
Zurück zum Zitat Drewnowski A, Evans WJ (2001) Nutrition, physical activity, and quality of life in older adults: summary. J Gerontol Ser A Biol Sci Med Sci 56(2):89–94CrossRef Drewnowski A, Evans WJ (2001) Nutrition, physical activity, and quality of life in older adults: summary. J Gerontol Ser A Biol Sci Med Sci 56(2):89–94CrossRef
22.
Zurück zum Zitat Farr OM, Tsoukas MA, Mantzoros CS (2015) Leptin and the brain: influences on brain development, cognitive functioning and psychiatric disorders. Metabolism 64:114–130CrossRef Farr OM, Tsoukas MA, Mantzoros CS (2015) Leptin and the brain: influences on brain development, cognitive functioning and psychiatric disorders. Metabolism 64:114–130CrossRef
23.
Zurück zum Zitat Lu X-Y (2007) The leptin hypothesis of depression: a potential link between mood disorders and obesity? Curr Opin Pharmacol 7:648–652CrossRef Lu X-Y (2007) The leptin hypothesis of depression: a potential link between mood disorders and obesity? Curr Opin Pharmacol 7:648–652CrossRef
24.
Zurück zum Zitat Huang EJ, Reichardt LF (2001) Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 24:677–736CrossRef Huang EJ, Reichardt LF (2001) Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 24:677–736CrossRef
25.
Zurück zum Zitat Pan A, Keum N, Okereke OI, Sun Q, Kivimaki M, Rubin RR, Hu FB (2012) Bidirectional association between depression and metabolic syndrome: a systematic review and meta-analysis of epidemiological studies. Diabetes Care 35:1171–1180CrossRef Pan A, Keum N, Okereke OI, Sun Q, Kivimaki M, Rubin RR, Hu FB (2012) Bidirectional association between depression and metabolic syndrome: a systematic review and meta-analysis of epidemiological studies. Diabetes Care 35:1171–1180CrossRef
26.
Zurück zum Zitat Karege F, Schwald M, Cisse M (2002) Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci Lett 328:261–264CrossRef Karege F, Schwald M, Cisse M (2002) Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci Lett 328:261–264CrossRef
27.
Zurück zum Zitat Hashimoto K (2010) Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions. Psychiatry Clin Neurosci 64:341–357CrossRef Hashimoto K (2010) Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions. Psychiatry Clin Neurosci 64:341–357CrossRef
28.
Zurück zum Zitat Hong C-J, Liou Y-J, Tsai S-J (2011) Effects of BDNF polymorphisms on brain function and behavior in health and disease. Brain Res Bull 86:287–297CrossRef Hong C-J, Liou Y-J, Tsai S-J (2011) Effects of BDNF polymorphisms on brain function and behavior in health and disease. Brain Res Bull 86:287–297CrossRef
29.
Zurück zum Zitat Zou Y-F, Wang Y, Liu P, Feng X-L, Wang B-Y, Zang T-H, Yu X, Wei J, Liu Z-C, Liu Y, Tao M, Li H-C, Li K-Q, Hu J, Li M, Zhang K-R, Ye D-Q, Xu X-P (2010) Association of BDNF Val66Met polymorphism with both baseline HRQOL scores and improvement in HRQOL scores in Chinese major depressive patients treated with fluoxetine. Hum Psychopharmacol 25:145–152CrossRef Zou Y-F, Wang Y, Liu P, Feng X-L, Wang B-Y, Zang T-H, Yu X, Wei J, Liu Z-C, Liu Y, Tao M, Li H-C, Li K-Q, Hu J, Li M, Zhang K-R, Ye D-Q, Xu X-P (2010) Association of BDNF Val66Met polymorphism with both baseline HRQOL scores and improvement in HRQOL scores in Chinese major depressive patients treated with fluoxetine. Hum Psychopharmacol 25:145–152CrossRef
30.
Zurück zum Zitat Chen C, Bazan NG (2005) Lipid signaling: sleep, synaptic plasticity, and neuroprotection. Prostaglandins Other Lipid Mediat 77:65–76CrossRef Chen C, Bazan NG (2005) Lipid signaling: sleep, synaptic plasticity, and neuroprotection. Prostaglandins Other Lipid Mediat 77:65–76CrossRef
31.
Zurück zum Zitat Boneva NB, Yamashima T (2012) New insights into “GPR40-CREB interaction in adult neurogenesis” specific for primates. Hippocampus 22:896–905CrossRef Boneva NB, Yamashima T (2012) New insights into “GPR40-CREB interaction in adult neurogenesis” specific for primates. Hippocampus 22:896–905CrossRef
32.
Zurück zum Zitat Sprecher H (2000) Metabolism of highly unsaturated n-3 and n-6 fatty acids. Biochim Biophys Acta 1486:219–231CrossRef Sprecher H (2000) Metabolism of highly unsaturated n-3 and n-6 fatty acids. Biochim Biophys Acta 1486:219–231CrossRef
33.
Zurück zum Zitat Ferreira CF, Bernardi JR, Bosa VL, Schuch I, Goldani MZ, Kapczinski F, Salum GA, Dalmaz C, Manfro GG, Silveira PP (2014) Correlation between n-3 polyunsaturated fatty acids consumption and BDNF peripheral levels in adolescents. Lipids Health Dis 13:44CrossRef Ferreira CF, Bernardi JR, Bosa VL, Schuch I, Goldani MZ, Kapczinski F, Salum GA, Dalmaz C, Manfro GG, Silveira PP (2014) Correlation between n-3 polyunsaturated fatty acids consumption and BDNF peripheral levels in adolescents. Lipids Health Dis 13:44CrossRef
34.
Zurück zum Zitat Zingone F, Iavarone A, Tortora R, Imperatore N, Pellegrini L, Russo T, Dorn SD, Ciacci C (2013) The Italian translation of the celiac disease-specific quality of life scale in celiac patients on gluten free diet. Dig Liver Dis 45:115–118CrossRef Zingone F, Iavarone A, Tortora R, Imperatore N, Pellegrini L, Russo T, Dorn SD, Ciacci C (2013) The Italian translation of the celiac disease-specific quality of life scale in celiac patients on gluten free diet. Dig Liver Dis 45:115–118CrossRef
36.
Zurück zum Zitat Svedlund J, Sjodin I, Dotevall G (1988) GSRS—a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 33:129–134CrossRef Svedlund J, Sjodin I, Dotevall G (1988) GSRS—a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 33:129–134CrossRef
37.
Zurück zum Zitat El-Salhy M, Hatlebakk JG, Gilja OH, Hausken T (2015) The relation between celiac disease, nonceliac gluten sensitivity and irritable bowel syndrome. Nutr J 14:92CrossRef El-Salhy M, Hatlebakk JG, Gilja OH, Hausken T (2015) The relation between celiac disease, nonceliac gluten sensitivity and irritable bowel syndrome. Nutr J 14:92CrossRef
38.
Zurück zum Zitat Antonioli DA (2003) Celiac disease: a progress report. Mod Pathol 16:342–346CrossRef Antonioli DA (2003) Celiac disease: a progress report. Mod Pathol 16:342–346CrossRef
39.
Zurück zum Zitat Russo F, Chimienti G, Clemente C, D’Attoma B, Linsalata M, Orlando A, De Carne M, Cariola F, Semeraro FP, Pepe G, Riezzo G (2013) Adipokine profile in celiac patients: differences in comparison with patients suffering from diarrhea-predominant IBS and healthy subjects. Scand J Gastroenterol 48:1377–1385. doi:10.3109/00365521.2013.845907 CrossRef Russo F, Chimienti G, Clemente C, D’Attoma B, Linsalata M, Orlando A, De Carne M, Cariola F, Semeraro FP, Pepe G, Riezzo G (2013) Adipokine profile in celiac patients: differences in comparison with patients suffering from diarrhea-predominant IBS and healthy subjects. Scand J Gastroenterol 48:1377–1385. doi:10.​3109/​00365521.​2013.​845907 CrossRef
40.
Zurück zum Zitat Gibert A, Espadaler M, Angel Canela M, Sanchez A, Vaque C, Rafecas M (2006) Consumption of gluten-free products: should the threshold value for trace amounts of gluten be at 20, 100 or 200 p.p.m.? Eur J Gastroenterol Hepatol 18:1187–1195CrossRef Gibert A, Espadaler M, Angel Canela M, Sanchez A, Vaque C, Rafecas M (2006) Consumption of gluten-free products: should the threshold value for trace amounts of gluten be at 20, 100 or 200 p.p.m.? Eur J Gastroenterol Hepatol 18:1187–1195CrossRef
41.
Zurück zum Zitat Chen S-P, Fuh J-L, Wang S-J, Tsai S-J, Hong C-J, Yang AC (2011) Brain-derived neurotrophic factor gene Val66Met polymorphism modulates reversible cerebral vasoconstriction syndromes. PLoS ONE 6:e18024CrossRef Chen S-P, Fuh J-L, Wang S-J, Tsai S-J, Hong C-J, Yang AC (2011) Brain-derived neurotrophic factor gene Val66Met polymorphism modulates reversible cerebral vasoconstriction syndromes. PLoS ONE 6:e18024CrossRef
42.
Zurück zum Zitat Hallert C, Astrom J, Sedvall G (1982) Psychic disturbances in adult coeliac disease. III. Reduced central monoamine metabolism and signs of depression. Scand J Gastroenterol 17:25–28CrossRef Hallert C, Astrom J, Sedvall G (1982) Psychic disturbances in adult coeliac disease. III. Reduced central monoamine metabolism and signs of depression. Scand J Gastroenterol 17:25–28CrossRef
43.
Zurück zum Zitat Addolorato G, Di Giuda D, De Rossi G, Valenza V, Domenicali M, Caputo F, Gasbarrini A, Capristo E, Gasbarrini G (2004) Regional cerebral hypoperfusion in patients with celiac disease. Am J Med 116:312–317CrossRef Addolorato G, Di Giuda D, De Rossi G, Valenza V, Domenicali M, Caputo F, Gasbarrini A, Capristo E, Gasbarrini G (2004) Regional cerebral hypoperfusion in patients with celiac disease. Am J Med 116:312–317CrossRef
44.
Zurück zum Zitat Ozsoy S, Besirli A, Abdulrezzak U, Basturk M (2014) Serum ghrelin and leptin levels in patients with depression and the effects of treatment. Psychiatry Investig 11:167–172CrossRef Ozsoy S, Besirli A, Abdulrezzak U, Basturk M (2014) Serum ghrelin and leptin levels in patients with depression and the effects of treatment. Psychiatry Investig 11:167–172CrossRef
45.
Zurück zum Zitat Cheung CK, Wu JC-Y (2013) Role of ghrelin in the pathophysiology of gastrointestinal disease. Gut Liver 7:505–512CrossRef Cheung CK, Wu JC-Y (2013) Role of ghrelin in the pathophysiology of gastrointestinal disease. Gut Liver 7:505–512CrossRef
46.
Zurück zum Zitat Carvalho AF, Rocha DQC, McIntyre RS, Mesquita LM, Kohler CA, Hyphantis TN, Sales PMG, Machado-Vieira R, Berk M (2014) Adipokines as emerging depression biomarkers: a systematic review and meta-analysis. J Psychiatr Res 59:28–37CrossRef Carvalho AF, Rocha DQC, McIntyre RS, Mesquita LM, Kohler CA, Hyphantis TN, Sales PMG, Machado-Vieira R, Berk M (2014) Adipokines as emerging depression biomarkers: a systematic review and meta-analysis. J Psychiatr Res 59:28–37CrossRef
47.
Zurück zum Zitat Karmiris K, Koutroubakis IE, Kouroumalis EA (2008) Leptin, adiponectin, resistin, and ghrelin–implications for inflammatory bowel disease. Mol Nutr Food Res 52:855–866CrossRef Karmiris K, Koutroubakis IE, Kouroumalis EA (2008) Leptin, adiponectin, resistin, and ghrelin–implications for inflammatory bowel disease. Mol Nutr Food Res 52:855–866CrossRef
48.
Zurück zum Zitat Yu Y-B, Zuo X-L, Zhao Q-J, Chen F-X, Yang J, Dong Y-Y, Wang P, Li Y-Q (2012) Brain-derived neurotrophic factor contributes to abdominal pain in irritable bowel syndrome. Gut 61:685–694CrossRef Yu Y-B, Zuo X-L, Zhao Q-J, Chen F-X, Yang J, Dong Y-Y, Wang P, Li Y-Q (2012) Brain-derived neurotrophic factor contributes to abdominal pain in irritable bowel syndrome. Gut 61:685–694CrossRef
49.
Zurück zum Zitat Brown GW, Craig TK, Harris TO, Herbert J, Hodgson K, Tansey KE, Uher R (2014) Functional polymorphism in the brain-derived neurotrophic factor gene interacts with stressful life events but not childhood maltreatment in the etiology of depression. Depress Anxiety 31:326–334. doi:10.1002/da.22221 CrossRef Brown GW, Craig TK, Harris TO, Herbert J, Hodgson K, Tansey KE, Uher R (2014) Functional polymorphism in the brain-derived neurotrophic factor gene interacts with stressful life events but not childhood maltreatment in the etiology of depression. Depress Anxiety 31:326–334. doi:10.​1002/​da.​22221 CrossRef
50.
Zurück zum Zitat Solakivi T, Kaukinen K, Kunnas T, Lehtimaki T, Maki M, Nikkari ST (2009) Serum fatty acid profile in celiac disease patients before and after a gluten-free diet. Scand J Gastroenterol 44:826–830CrossRef Solakivi T, Kaukinen K, Kunnas T, Lehtimaki T, Maki M, Nikkari ST (2009) Serum fatty acid profile in celiac disease patients before and after a gluten-free diet. Scand J Gastroenterol 44:826–830CrossRef
51.
Zurück zum Zitat van Hees NJM, Giltay EJ, Geleijnse JM, Janssen N, van der Does W (2014) DHA serum levels were significantly higher in celiac disease patients compared to healthy controls and were unrelated to depression. PLoS ONE 9:e97778CrossRef van Hees NJM, Giltay EJ, Geleijnse JM, Janssen N, van der Does W (2014) DHA serum levels were significantly higher in celiac disease patients compared to healthy controls and were unrelated to depression. PLoS ONE 9:e97778CrossRef
52.
Zurück zum Zitat Balanza-Martinez V, Fries GR, Colpo GD, Silveira PP, Portella AK, Tabares-Seisdedos R, Kapczinski F (2011) Therapeutic use of omega-3 fatty acids in bipolar disorder. Expert Rev Neurother 11:1029–1047CrossRef Balanza-Martinez V, Fries GR, Colpo GD, Silveira PP, Portella AK, Tabares-Seisdedos R, Kapczinski F (2011) Therapeutic use of omega-3 fatty acids in bipolar disorder. Expert Rev Neurother 11:1029–1047CrossRef
Metadaten
Titel
A possible role for ghrelin, leptin, brain-derived neurotrophic factor and docosahexaenoic acid in reducing the quality of life of coeliac disease patients following a gluten-free diet
verfasst von
Francesco Russo
Guglielmina Chimienti
Caterina Clemente
Carla Ferreri
Antonella Orlando
Giuseppe Riezzo
Publikationsdatum
21.12.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nutrition / Ausgabe 2/2017
Print ISSN: 1436-6207
Elektronische ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-015-1128-2

Weitere Artikel der Ausgabe 2/2017

European Journal of Nutrition 2/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.